Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Verapamil for Respiratory Symptom Improvement in COPD
IRCT20251014067618N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of verapamil in chronic obstructive pulmonary disease (COPD), sponsored by Kurdistan University of Medical Sciences. Started Nov 2025; status: completed.
02
Drugs
verapamil
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on IRCT20251014067618N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251014067618N1.